The Drug Enforcement Administration (DEA) is proposing a significant increase in the amount of research cannabis that can be grown in 2023. according to a note Due to be published in the Federal Register on Tuesday, the agency also wants to increase the overall production quota of certain psychedelics such as LSD, psilocin and mescaline, First reported marijuana moment.
For 2023, The DEA proposes that 6.7 million grams (14,770 pounds) of marijuana be grown for research purposes, more than double the amount proposed for 2022 (3.2 million grams).. In January of this year, the DEA ended a 5 decade long federal monopoly on cannabis production for research by approving two companies, Groff North America Hemplex and Biopharmaceutical Research Company (BRC), to grow marijuana for research.
This was an important milestone in the field of cannabis research because a Farm works as part of University of Mississippi has nevertheless been the only legal source of federal research cannabis since 1968 complain and years of complaints that Ole Miss’s product wasn’t high enough enough for important research.
As more growers gain DEA approval to grow, an increase in the amount needed for research is achievable.
In addition, the DEA also increased the quota for “all other THC” to 15,000 grams from the previous 2,000 grams. indicating the popularity and therefore the need for research into cannabinoids Delta-8 THCand Delta-10.
Psychedelics are also in the mix
The agency has increased production quotas for psychedelics in recent years. For example last December increased his rate for psilocybin (aka magic mushrooms), MDMA and DMT for 2022. This move comes amid increasing demand and interest within the scientific community to explore the effectiveness of these psychedelics in treating mental disorders.
This time the DEA suggested keeping them same quote for…
